TY  - GEN
AU  - Higuchi,Tomoko
AU  - Soga,Yoshihiko
AU  - Muro,Misato
AU  - Kajizono,Makoto
AU  - Kitamura,Yoshihisa
AU  - Sendo,Toshiaki
AU  - Sasaki,Akira
TI  - Replacing zoledronic acid with denosumab is a risk factor for developing osteonecrosis of the jaw
SN  - 2212-4411
PY  - 2018///1113
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Bisphosphonate-Associated Osteonecrosis of the Jaw
KW  - etiology
KW  - Bone Density Conservation Agents
KW  - administration & dosage
KW  - Bone Neoplasms
KW  - drug therapy
KW  - Denosumab
KW  - Diphosphonates
KW  - Female
KW  - Humans
KW  - Imidazoles
KW  - Japan
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Risk Factors
KW  - Zoledronic Acid
N1  - Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.oooo.2018.02.010
ER  -